Skip to content
TriangleGet started
← Childhood Non-Hodgkin Lymphoma

FOR PATIENTS · SOURCE READING

Treatment of post-transplant lymphoproliferative disease

Source: Childhood Non-Hodgkin Lymphoma Treatment (PDQ®)–Patient Version, National Cancer Institute.

Source updated: May 9, 2025 · Captured 2026-09-09.

Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary. Independent clinical review is pending.

Context: Treatment Options for Childhood Non-Hodgkin Lymphoma / Lymphoproliferative Disease Associated With Immunodeficiency in Children

For information about the treatments listed below, see Treatment Option Overview.

Source links and citations

Treatment of post-transplant lymphoproliferative disease may include:

Source links and citations

Surgery to remove the tumor. If possible, lower doses of immunosuppressive drugs after a stem cell or organ transplant may be given.

Source links and citations

Targeted therapy (rituximab).

Source links and citations

Chemotherapy with or without targeted therapy (rituximab).

Preserved source evidence · Independent clinical review pending · Not medical advice